Join
Live feed
·
INSIDERFilingvia Quantisnow
Unity Biotechnology Inc. logo

Chief Executive Officer Ghosh Anirvan was granted 175,000 shares, increasing direct ownership by 233% to 250,251 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
UBX· Unity Biotechnology Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track UBX (Unity Biotechnology Inc.) and more on Quantisnow.